Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Thomas Ondra, Alex Dmitrienko, Tim Friede, Alexandra Graf, Frank Miller, Nigel Stallard & Martin Posch. (2016) Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review. Journal of Biopharmaceutical Statistics 26:1, pages 99-119.
Read now
Read now
Articles from other publishers (19)
Chiara Arienti, Michele Patrini, Stefano Negrini & Carlotte Kiekens. (2023) Overview of Cochrane Systematic Reviews for Rehabilitation Interventions in Persons With Spinal Cord Injury: A Mapping Synthesis. Archives of Physical Medicine and Rehabilitation 104:1, pages 143-150.
Crossref
Crossref
James Heyward, Milena Lolic, Catherine Spong, David Atkins, Gene Pennello & Ravi Varadhan. (2021) Assessing and communicating heterogeneity of treatment effects for patient subpopulations: Keynote and panel discussion on communicating heterogeneous treatment effects across populations. Pharmaceutical Statistics 20:5, pages 965-978.
Crossref
Crossref
Siyun Yang, Elizabeth Lorenzi, Georgia Papadogeorgou, Daniel M. Wojdyla, Fan Li & Laine E. Thomas. (2021) Propensity score weighting for causal subgroup analysis. Statistics in Medicine 40:19, pages 4294-4309.
Crossref
Crossref
Martijn J.L. Bours. (2021) Tutorial: A nontechnical explanation of the counterfactual definition of effect modification and interaction. Journal of Clinical Epidemiology 134, pages 113-124.
Crossref
Crossref
Mahmood AminiLari, Vahid Ashoorian, Alexa Caldwell, Yasir Rahman, Robby Nieuwlaat, Jason W. Busse & Lawrence Mbuagbaw. (2021) The quality of subgroup analyses in chronic pain randomized controlled trials: a methodological review. The Korean Journal of Pain 34:2, pages 139-155.
Crossref
Crossref
Garritt L. Page, Fernando A. Quintana & Gary L. Rosner. (2021) Discovering interactions using covariate informed random partition models. The Annals of Applied Statistics 15:1.
Crossref
Crossref
Jun Yu & Dejian Lai. (2019) Sequential monitoring of covariate adaptive randomized clinical trials with sample size re-estimation. Contemporary Clinical Trials 87, pages 105874.
Crossref
Crossref
Gerd Rosenkranz. 2019. Exploratory Subgroup Analyses in Clinical Research. Exploratory Subgroup Analyses in Clinical Research
197
215
.
Hanan Aboumatar, Mohammad Naqibuddin, Suna Chung, Hina Chaudhry, Samuel W. Kim, Jamia Saunders, Lee Bone, Ayse P. Gurses, Amy Knowlton, Peter Pronovost, Nirupama Putcha, Cynthia Rand, Debra Roter, Carol Sylvester, Carol Thompson, Jennifer L. Wolff, Judith Hibbard & Robert A. Wise. (2019) Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary Disease. JAMA 322:14, pages 1371.
Crossref
Crossref
Stefan Schandelmaier, Yaping Chang, Niveditha Devasenapathy, Tahira Devji, Joey S.W. Kwong, Luis E. Colunga Lozano, Yung Lee, Arnav Agarwal, Neera Bhatnagar, Hannah Ewald, Ying Zhang, Xin Sun, Lehana Thabane, Michael Walsh, Matthias Briel & Gordon H. Guyatt. (2019) A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses. Journal of Clinical Epidemiology 113, pages 159-167.
Crossref
Crossref
Christoph Muysers, Alex Dmitrienko, Hermann Kulmann, Bodo Kirsch, Susanne Lippert, Thomas Schmelter, Anke Schulz, Nicole Mentenich, Heinz Schmitz, Matthias Schaefers, Gerold Meinhardt, Thomas Keil & Stephanie Roll. (2019) A Systematic Approach for Post Hoc Subgroup Analyses With Applications in Clinical Case Studies. Therapeutic Innovation & Regulatory Science, pages 216847901985378.
Crossref
Crossref
Nicolás M. Ballarini, Gerd K. Rosenkranz, Thomas Jaki, Franz König & Martin Posch. (2018) Subgroup identification in clinical trials via the predicted individual treatment effect. PLOS ONE 13:10, pages e0205971.
Crossref
Crossref
Catherine R. Lesko, Nicholas C. Henderson & Ravi Varadhan. (2018) Considerations when assessing heterogeneity of treatment effect in patient-centered outcomes research. Journal of Clinical Epidemiology 100, pages 22-31.
Crossref
Crossref
Charlotte Koopal, Frank L.J. Visseren, Jan Westerink, Yolanda van der Graaf, Henry N. Ginsberg & Anthony C. Keech. (2018) Predicting the Effect of Fenofibrate on Cardiovascular Risk for Individual Patients With Type 2 Diabetes. Diabetes Care 41:6, pages 1244-1250.
Crossref
Crossref
Gene Pennello & Mark Rothmann. 2018. Biopharmaceutical Applied Statistics Symposium. Biopharmaceutical Applied Statistics Symposium
175
192
.
Mohamed AloshMohammad F. HuqueFrank Bretz & Ralph B. D'AgostinoSr.Sr.. (2017) Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials. Statistics in Medicine 36:8, pages 1334-1360.
Crossref
Crossref
Julien Tanniou, Ingeborg van der Tweel, Steven Teerenstra & Kit C. B. Roes. (2016) Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes. BMC Medical Research Methodology 16:1.
Crossref
Crossref
Nicholas C. Henderson, Thomas A. Louis, Chenguang Wang & Ravi Varadhan. (2016) Bayesian analysis of heterogeneous treatment effects for patient-centered outcomes research. Health Services and Outcomes Research Methodology 16:4, pages 213-233.
Crossref
Crossref
Ravi Varadhan & Sue-Jane Wang. (2016) Treatment effect heterogeneity for univariate subgroups in clinical trials: Shrinkage, standardization, or else. Biometrical Journal 58:1, pages 133-153.
Crossref
Crossref